BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2022 9:49:51 AM | Browse: 247 | Download: 620
 |
Received |
|
2022-09-17 16:26 |
|
Peer-Review Started |
|
2022-09-17 16:27 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-10-19 04:16 |
|
Revised |
|
2022-10-25 14:16 |
|
Second Decision |
|
2022-11-14 03:27 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-11-17 18:18 |
|
Articles in Press |
|
2022-11-17 18:18 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-11-10 01:29 |
|
Typeset the Manuscript |
|
2022-11-23 10:06 |
|
Publish the Manuscript Online |
|
2022-12-02 09:49 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Rifabutin as salvage therapy for Helicobacter pylori eradication: Cornerstones and novelties
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Antonia Valeria Borraccino, Francesca Celiberto, Maria Pricci, Bruna Girardi, Andrea Iannone, Maria Rendina, Enzo Ierardi, Alfredo Di Leo and Giuseppe Losurdo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Giuseppe Losurdo, MD, Assistant Professor, Doctor, Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Piazza Giulio Cesare 11, Bari 70124, Italy. giuseppelos@alice.it |
| Key Words |
Helicobacter pylori; Eradication; Rifabutin; Antibiotic resistance; Rescue therapy; Treatment |
| Core Tip |
Rifabutin is an antibiotic that is commonly used to treat tuberculosis or atypical mycobacteria. However, it shows antimicrobial effect against Helicobacter pylori as well. It is indicated when multiple eradication treatments have failed. In this review, we summarized current evidence about traditional triple therapy containing amoxicillin and rifabutin as salvage therapy, based on the most recent meta-analyses. Furthermore, other novelties regarding rifabutin based regimens have been mentioned. |
| Publish Date |
2022-12-02 09:49 |
| Citation |
Borraccino AV, Celiberto F, Pricci M, Girardi B, Iannone A, Rendina M, Ierardi E, Di Leo A, Losurdo G. Rifabutin as salvage therapy for Helicobacter pylori eradication: Cornerstones and novelties. World J Gastroenterol 2022; 28(45): 6356-6362 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i45/6356.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i45.6356 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
